The new facility aims to strengthen food security and modern animal nutrition in Southeast Asia.
For Diasham, the acquisition marks a transition aimed at scaling its legacy beyond its traditional markets.
By localising its operations, Royal Canin says it will provide more accessible services and strengthen its role as a trusted partner in advancing pet health.
Unlike human food, however, cultivated pet food ingredients do not need pre-market approval, meaning Umami Bioworks could fast-track its entry.
The new centre focuses on breeding tilapia with traits such as reddish-golden skin, strong disease resistance, and the ability to grow to at least 1kg—ideal for filleting and commercial sale.